Drug Master Files for: CLONAZEPAM
✉ Email this page to a colleague
CLONAZEPAM Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
11351 | A | II | 2/17/1995 | CAMBREX PROFARMACO MILANO SRL | CLONAZEPAM |
11897 | I | II | 3/21/1996 | HOECHST CELANESE CORP | CLONAZEPAM |
12986 | I | II | 5/11/1998 | ZHEJIANG HISUN PHARMACEUTICAL CO LTD | CLONAZEPAM, USP |
16245 | A | II | 11/15/2002 | PAR A TECHNOLOGIES PRIVATE LTD | CLONAZEPAM |
17727 | A | II | 10/6/2004 | SUN PHARMACEUTICAL INDUSTRIES LTD | CLONAZEPAM USP |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information